Austco Healthcare (AHC) H2 2026 earnings summary

Executive summary

• Achieved record revenue of $94.2 million, up 16% year-over-year, and EBITDA of $14.9 million, up 14%.

• NPAT surged 52% to $9.0 million, reflecting improved profitability and operational leverage.

• Expanded to over 5,000 facilities in 60+ countries, with direct operations in 6 countries.

• Integrated four acquired businesses while maintaining profitability and investing in innovation.

• Unfilled Contracted Revenue (UCR) rose to $51.2 million as of August 2026, up 13% since June 2026.

Financial highlights

• Gross margin improved by 140bp to 53.4% due to lower input prices and supply chain efficiencies.

• EBITDA margin was 15.8%, slightly down from 16.0% year-over-year.

• NPAT rose 51.8% to $9.0 million; underlying NPAT was $8.1 million, flat year-over-year excluding one-time items.

• Software and maintenance revenue grew 19% to $11.4 million, now 12% of group revenue.

• Cash balance increased to $16.3 million, with $12.5 million generated from operating activities.

Outlook and guidance

• Entering FY27 with a strong sales pipeline and $51.2 million in unfilled contracted revenue as of August 2026.

• Focus on expanding recurring revenue, enhancing margin profile, and disciplined M&A.

• Continued investment in AI-driven innovation and platform development.

• Demand is supported by demographic trends and workforce shortages, with integrated acquisitions and lower input costs expected to further benefit results.

• The timing of hospital capital programs remains the main variable for future performance.